Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for sedation in gastroscopy (phase II, China)
CTR20160908Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of remimazolam in anxiety disorder, sponsored by Hengrui Therapeutics. Started Nov 2016; status: completed.
02
Drugs
remimazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on CTR20160908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160908.